Anxiety News and Research

Latest Anxiety News and Research

Omeros receives additional NIDA grant for clinical studies in Addiction program

Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute.

14 Oct 2010

Five tips to sustain couple relationship

In honor of Emotional Wellness Month this October, the California Association of Marriage and Family Therapists (CAMFT) has released a podcast to help couples keep the flame alive.

14 Oct 2010

EFNS recommends use of DaTSCAN injection with SPECT imaging for AD diagnosis

GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.

14 Oct 2010

Researchers report prevalence data on mental disorders among U.S. adolescents

Mental disorders in children are often difficult to identify due to the myriad of changes that occur during the normal course of maturation. For the first time, researchers at the National Institute of Mental Health have reported on the prevalence data on a broad range of mental disorders in a nationally representative sample of U.S. adolescents, which show that approximately one in five children in the U.S. meet the criteria for a mental disorder severe enough to disrupt their daily lives.

14 Oct 2010

GSA and NAM select journalists for new MetLife Foundation Journalists in Aging Fellows Program

The Gerontological Society of America (GSA) and New America Media (NAM) have selected 15 journalists for the new MetLife Foundation Journalists in Aging Fellows Program. They represent a wide range of traditional, new, and ethnic media, such as USA Today, Sing Tao Daily, the Minneapolis Star Tribune, and TheAtlantic.com.

14 Oct 2010

Yoga exercises may combat fibromyalgia: Research

According to new research conducted at Oregon Health & Science University, yoga exercises may have the power to combat fibromyalgia a medical disorder characterized by chronic widespread pain. The research is being published in the November 10 online edition of the journal Pain and will appear online Thursday, Oct. 14.

14 Oct 2010

AGA's new book offers strategies to reduce IBS symptoms

A new book from the American Gastroenterological Association (AGA) offers patients with irritable bowel syndrome (IBS) a variety of strategies to lessen the burden that IBS puts on their everyday lives. IBS is a common disorder of the intestines that leads to crampy pain, gassiness, bloating and changes in bowel habits; there is no cure. The new book, "Master Your IBS," includes a variety of strategies to help patients learn how to manage their IBS symptoms and achieve greater freedom from IBS.

14 Oct 2010

Antidepressant Reboxetine ineffective: Review

According to a new study, an antidepressant prescribed over the last 13 years is ineffective and potentially harmful. The drug in question is called Reboxetine and is available under the name of Edronax. The study showed that it works no better than a placebo.

13 Oct 2010

Genmab and Lundbeck enter agreement to develop antibody therapeutics

Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.

13 Oct 2010

Commercial genetic profiling services should provide detailed information about test results: Report

Direct-to-consumer personal genetic profiling services that claim to predict people's health risks by analysing their DNA are often inconclusive and companies that sell them should provide better information about the evidence on which the results are based, says the UK Nuffield Council on Bioethics, in a new report on the ethics of so-called personalised healthcare services.

13 Oct 2010

Trapped Chilean miners might be changed forever: Psychologists

The Chilean miners who have been trapped for more than two months may emerge with psychological problems say experts as the rescue approached. Rescue teams were set to start hoisting up the first of 33 miners, trapped down around 700 metres, to the surface around midnight on Tuesday (1400 AEDT Wednesday), Mines Minister Laurence Golborne said.

12 Oct 2010

Australian women stressed and overweight: Survey

In a poll known as “Australia's Biggest Health Check” 26,000 responders showed that Australia's women feel stressed out and unfit and overworked. It also shows that they have barely half an hour of leisure time per day and the mismatch between how much sex women want versus what they get. The survey was promoted via two magazines - Women's Health and Prevention - and also had the backing of Priceline and the Seven Network’s Sunrise program. There were 24,500 women and 1,500 men in on the poll.

12 Oct 2010

Lundbeck, Merck announce commercialization agreement for SYCREST sublingual tablets

H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.

12 Oct 2010

Fertility concerns of cancer survivors inadequately addressed, study finds

Many cancer survivors experience changes in sexual function that leave them feeling guilty and a longing for intimacy, Australian researchers told at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy. The researchers say that these sexuality and fertility concerns are often not adequately addressed by doctors.

11 Oct 2010

Yoga decreases anxiety in childhood cancer patients and their parents

A new study reports that yoga can reduce the stress of cancer diagnosis and treatment experienced by childhood cancer patients and their parents. The findings were published in the September/October 2010 edition of Journal of Pediatric Oncology Nursing, published by the Association of Pediatric Hematology/Oncology Nurses (APHON).

11 Oct 2010

FDA warns of harmful stimulant in Slimming Beauty capsules

The U.S. Food and Drug Administration today advised consumers who have Slimming Beauty Bitter Orange Slimming Capsules not to use the product. FDA warns that Slimming Beauty Bitter Orange Slimming Capsules contain the active pharmaceutical ingredient sibutramine, a prescription-only drug which is a stimulant. Sibutramine is not listed on the product label and could harm consumers, especially those with cardiovascular conditions.

11 Oct 2010

Some herbal remedies for anxiety disorders effective

Two herbal remedies from passion flower extract and kava have shown to be effective in alleviating anxiety say scientists. The results came from an analysis of 24 studies involving more than 2,000 participants which also showed that combinations of the amino acids L-lysine and L-arginine may be useful anxiety remedies.

10 Oct 2010

Hard combat can devastate veterans until old age

The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.

8 Oct 2010

New instrument to determine anxiety level

A new instrument developed by a Washington and Lee University psychologist is designed to help clinicians determine more objectively a patient's level of anxiety.

8 Oct 2010

Childhood abuse may lead to physiological consequences later in life

Seemingly healthy adults, if they were abused or neglected during childhood, may suffer physiological consequences decades later. In research published online last week by the journal Neuropsychopharmacology, a team led by psychiatrists at Brown University and Butler Hospital found that healthy adults who reported being mistreated as kids appear to have an elevated inflammatory response to stress compared to adults who had happier childhoods.

8 Oct 2010